Security key
00510M203
Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (ACXP)
CUSIP: 00510M203
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, Par Value $0.01 per share
- Total 13F shares
- 138,609
- Total 13F value
- $345,155
- Share change
- +82,816
- SEC-reported price per share
- $2.49
- Number of holders
- 18
- Value change
- +$158,169
- Number of buys
- 10
- Number of sells
- 10
- Shares outstanding
- 12,886,256
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
18
Top holders
10
ACXP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Acurx Pharmaceuticals, Inc. SEC filings
Acurx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00510M203
Recent filing periods:
Ownership snapshot
Top reported holders of ACXP - Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Prospect Financial Servic...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Virtu Financial LLC
0.97%
GEODE CAPITAL MANAGEMENT, LLC
0.86%
TWO SIGMA SECURITIES, LLC
0.66%
Prospect Financial Services LLC
0.15%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$62,591
83,233 shares
|
-$2,131,726 | 30 Sep 2025 |
| Virtu Financial LLC |
13F
Company
|
0.97%
|
$12,000
16,225 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.86%
|
$10,793
14,350 shares
|
— | 30 Sep 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.66%
|
$8,261
10,982 shares
|
— | 30 Sep 2025 |
| Prospect Financial Services LLC |
13F
Company
|
0.15%
|
$85,302
19,883 shares
|
— | 30 Sep 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.13%
|
$72,136
16,815 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
138,609
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
16
Q4 2025 holders
18
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend